Elicio Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Elicio Therapeutics (ELTX) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Elicio Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Elicio Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv

Quarterly reported holdings in Elicio Therapeutics by UBS Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-12-31 | $86 | 17 | 5.12 |
2024-09-30 | $4.3k | 848 | 5.06 |
2024-06-30 | $69 | 17 | 4.12 |
2024-03-31 | $122 | 16 | 7.63 |
2023-12-31 | $133 | 16 | 8.31 |
2023-09-30 | $135 | 16 | 8.44 |
2023-06-30 | $6.1k | 645 | 9.50 |